Lorence Kim
Board Member
Revolution Medicines, Inc. (RVMD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lorence Kim
Lorence Kim is recorded as CFO at Moderna, Inc. (MRNA) and Board Member at Revolution Medicines, Inc. (RVMD). The proxy statement of Moderna, Inc. reports total compensation of $3,393,986 for Lorence Kim in fiscal 2020, including a base salary of $418,211. Disclosed compensation is on record for 4 fiscal years. Lorence Kim has spoken on 1 earnings call across 1 company, most recently for Moderna, Inc. on May 7, 2020.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Moderna, Inc.
Other people whose current roles at this company are on record from its filings.
- Stéphane Bancel CEO, Board Member
- Noubar Afeyan Chairman, Board Member
- David W. Meline CFO
- James Mock CFO
- Jorge M. Gomez CFO
- Juan Andres COO
- Dr. Jerh Collins CTO
- Lori Henderson General Counsel
- Abbas Hussain Board Member
- Continuing Directors Board Member
Leadership on record at Revolution Medicines, Inc.
Other people whose current roles at this company are on record from its filings.
- Mark Goldsmith CEO, Board Member
- Jack Anders CFO
- Margaret Horn COO
- Jeffrey Cislini General Counsel
- Alexis Borisy Board Member
- Elizabeth McKee Anderson Board Member
- Eric Schmidt Board Member
- Flavia Borellini Board Member
- Frank K. Clyburn Board Member
- Frank K. Clyburn, Jr. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Moderna, Inc. (MRNA) | Former Chief Financial Officer | $418,211 | $3,393,986 |
| 2019 | Moderna, Inc. (MRNA) | Former Chief Financial Officer | $560,401 | $3,597,565 |
| 2018 | Moderna, Inc. (MRNA) | Former Chief Financial Officer | $542,769 | $9,038,117 |
| 2017 | Moderna, Inc. (MRNA) | Chief Financial Officer | $521,154 | $9,315,787 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.